# Modavar Pharmaceuticals – FDA Inspection, Jan 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/modavar-pharmaceuticals/d26160e6-dfa9-4457-8cd6-d8724c6675ac
Source feed: FDA_Inspections

> FDA inspection 1196541 of Modavar Pharmaceuticals, January 27, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196541
- Company Name: Modavar Pharmaceuticals
- Inspection Date: 2023-01-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 8

## Related Documents

- [FDA Inspection 1260535 - 2024-11-15](https://www.keypedia.com/records/fda_inspections/modavar-pharmaceuticals/685b62b2-4e0b-45fb-b813-b0df6f4d9737)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/amy-n-chen/c3515e0e-dbb9-4540-bd2b-82c06d00dd42)
- [Jazmine N. Brown](https://www.keypedia.com/people/jazmine-n-brown/194fc53f-942f-4e8c-a475-b7eac11be103)
- [Kathleen M. Jordan](https://www.keypedia.com/people/kathleen-m-jordan/e08b786a-47bf-4e78-ae96-9d94cdc20bdb)

Company: https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
